Industry landscapes
The companies, capital and talent shaping healthtech in Sweden. Find the leaders. Understand the segments. See where the activity is.
An industry ecosystem,
measured in context.
24 featured companies from the funding, hiring, revenue and team-size leaderboards.
Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗
No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.
Explore classified startups in Radar ↗A few useful ratios bring the size of this ecosystem into perspective.
50 of 1,000 tracked companies have open roles.
208 of 1,000 tracked companies have a recorded round.
Share of disclosed capital received by the three largest recorded recipients.
Midpoint of 302 rounds with a disclosed amount.
Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 47.4% of disclosed capital, while 79.2% of tracked companies have no recorded funding round.
Explore the segments →Recorded company formation and disclosed funding across the complete annual series shown.
Sum of recorded funding rounds · USD
| Year | Funding (USD) | Founded | Raising |
|---|---|---|---|
| 2016 | $93.41M | 68 | 26 |
| 2017 | $121.48M | 57 | 25 |
| 2018 | $171.32M | 59 | 30 |
| 2019 | $90.54M | 62 | 37 |
| 2020 | $354.32M | 64 | 33 |
| 2021 | $568.45M | 48 | 32 |
| 2022 | $264.13M | 28 | 24 |
| 2023 | $138.69M | 17 | 29 |
| 2024 | $140.54M | 8 | 16 |
| 2025 | $376.99M | 8 | 13 |
Share of all disclosed company funding.
368 recorded rounds since 2016
Recorded participation in healthtech company rounds since 2016.
Backed by Google Ventures and Lerer Hippeau and others.
Backed by Accel and Index Ventures and others.
Backed by Lightspeed Venture Partners and Lakestar and others.
Backed by Ontario Teachers' Pension Plan and Index Ventures and others.
Backed by Ontario Teachers' Pension Plan and Index Ventures and others.
Backed by Index Ventures and Accel and others.
Backed by Lakestar and Atomico and others.
Backed by Consensus Asset Management and Norron and others.
Backed by Lauxera Capital Partners and Point72 Ventures.
Backed by Kinnevik and Northzone and others.
Backed by Oriola and Handelsbanken and others.
No reviewed exact national-ID connector has yet been qualified for Sweden; this is a checked implementation boundary, not evidence that filings are absent.
How the Sweden companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.
19 of the 1,000 companies on this page carry a measured traffic record (1.9%); these are the largest of those, by monthly visits. The median among them is 380,764 visits.
| Company | Monthly visits | Authority | Mobile |
|---|---|---|---|
| Apoteaapotea.se | 5,073,403 | 61 | 75.4% |
| Apoteketapoteket.se | 2,437,688 | 61 | 79.3% |
| Apotek Hjrtatapotekhjartat.se | 2,109,377 | 58 | 81% |
| MEDSmeds.se | 989,325 | 49 | 79.2% |
| Apohemapohem.se | 841,590 | 51 | 72.3% |
| Neko Healthnekohealth.com | 553,543 | 39 | 91.1% |
| MM Sportsmmsports.se | 505,295 | 42 | 80.7% |
| internetmedicininternetmedicin.se | 434,599 | 54 | 54% |
| Sectrasectra.com | 381,676 | 35 | 74% |
| Min Doktormindoktor.se | 380,764 | 45 | 90.2% |
Visits and authority are third-party web estimates, not company-reported figures.
137 of these companies (13.7%) publish at least one Android app — 173 apps in all, carrying 42.4M installs between them.
| App | Installs | Rating | Store category |
|---|---|---|---|
| Sleep Cycle: Sleep TrackerSleep Cycle | 18.9M | 4.3 | Health & Fitness |
| Preglife - Pregnancy TrackerPreglife | 3.6M | 4.5 | Parenting |
| The Mindfulness AppThe Mindfulness App | 2.6M | 4.2 | Health & Fitness |
| Livi - See a doctor by videoKry | 2.5M | 4.6 | Medical |
| Kry - Healthcare by videoKry | 1.4M | 4.6 | Medical |
| Remente: Self Care, WellbeingRemente | 1.4M | 4.3 | Health & Fitness |
| Natural Cycles - Birth ControlNatural Cycles | 1.4M | 4.5 | Medical |
| Doktor.se - Trygg vård direktDoktor.se | 1.1M | 4.5 | Medical |
| Napper: Baby Sleep & ParentingNapper | 1M | 4.5 | Parenting |
| ApoteketApoteket | 1M | 4.3 | Medical |
Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.
The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2024Q1–2026Q2).
| Segment | Apps | Installs | Leading app | Release trend |
|---|---|---|---|---|
| Disease Self Management | 65 | 31.6M | Sleep Cycle: Sleep Tracker 18.9M | |
| Fitness & Wellness Tech | 15 | 21.7M | The Mindfulness App 2.6M | |
| Healthcare Booking Platforms | 41 | 8.4M | Livi - See a doctor by video 2.5M | |
| Healthcare It | 64 | 1.7M | Care to Translate 595.8K | |
| Employee Health It | 4 | 1.4M | Remente: Self Care, Wellbeing 1.4M | |
| Wearable Technology | 24 | 1.4M | Detecht - Motorcycle App & GPS 675.5K | |
| Assistive Tech | 14 | 847.3K | Sms-livräddare 152.3K | |
| Veterinary Healthtech | 3 | 700.1K | FirstVet 388.9K |
A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.
New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.
Darker bars are new releases, lighter bars apps updated. 116 of 173 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.
Explore the segments behind the headline numbers.
Rank segments by scale, hiring or disclosed funding.
Companies can sit in several segments. Counts and funding overlap.
The largest measured segment in this report snapshot.
25 companies hiring · $1.16B disclosed funding
Explore in RadarCommon revenue models; a company can use more than one.
Recorded corporate activity linked to companies in this landscape.
Vyta Health, an importer and distributor of vitamin and supplement brands, has acquired Bodystore, a Netherlands-based sports nutrition and supplements retailer with a 24-year track record online.
Getinge has acquired Pennamed, a Hull‑based specialist distributor of endoscopic consumables serving NHS trusts and private healthcare providers.
In light of the Company's collaboration with BDO LLP's UK Life Sciences M&A team regarding business development efforts in strategically important markets, it was resolved unanimously that the merger plans regarding the absorption of the wholly owned subsidiaries Klaria Incentive AB, Karessa Incentive AB and Karessa Pharma AB, established on May 24, 2025, shall be applicable in Klaria Pharma Holding AB (publ).
Senzime AB (publ.) (STO:SEZI)(OTCQX:SNZZF) announces that the company has secured a credit line facility of 50 MSEK. The credit facility has been issued at fair market terms by a group of existing shareholders including Crafoord and Segulah, as well DBT Capital, a part of Noba Bank Group.
NEOGAP Therapeutics AB , a biotech based in Sweden and led by CEO Samuel Svensson raised SEK 87 M ($9.5 M) financing.
The all-share transaction combines the two companies, with It Works! receiving $30 million in Zinzino B-shares.
Smart Eye Aktiebolag (publ) ('Smart Eye') has entered into an agreement to acquire all shares in the Swedish AI-based software company Sightic Analytics AB from its current shareholders for a fixed purchase price of SEK 60.5 million.
Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon').
Lund-based MedVasc has raised €2.2 million through subscriptions exclusively from existing shareholders
he announced on Tuesday the acquisition of NGIS in Australia
Top 10 categories among 354 recorded events in the 24-month window.
2 companies with recorded IPO activity
IPO1 reports
IPO · Nasdaq Stockholm2 reports
17 tracked people moves
Appointment Chief Financial Officer
Departure Previously Chief Operating Officer
Departure Previously Chief Financial Officer
Appointment Chief Medical Officer
Appointment Deputy Chief Executive Officer and Head of medical technology operations
Appointment Chief Executive Officer
Appointment Chief Financial Officer
Departure Previously Chief Financial Officer
8 recorded customer wins
Customer: FedEx Corp.Logistics
Customer: genetic tradingHealthcare
Customer: detmar logisticsOil and Gas
Customer: spotifyDigital music licensing
Customer: Connect Proton Therapy CenterMedical Technology
Customer: institut curie
1 companies with reported reductions
6 rolescost savings
5 recorded events
ongoing investigationSwedish Economic Crime Authority
trading haltFirst North Growth Market
pediatric indication approval received
approved for acquisitionGerman competition authority
2 tracked suits
suspected fraudulent financial transactionsCriminal · Filed
breaches of fiduciary duty and other violations of state lawRegulatory ·
Reported company results in the recorded window.
Median across 103 reported growth observations; companies may contribute multiple periods.
Company-linked deal reports; status is preserved as recorded.
| Acquirer → target | Status | Date | Value / context |
|---|---|---|---|
| Aurora Innovation→blackmore | Announced | 2026-05-23 | Not stated in snapshot |
| Vyta Health→bodystore ↗ | Completed | 2026-04-14 | Not stated in snapshot |
| Getinge→Pennamed | Completed | 2026-04-08 | Not stated in snapshot |
| Klaria→Klaria ↗ | Announced | 2026-03-19 | Not stated in snapshot |
| Klaria→Karessa | Announced | 2026-03-19 | Not stated in snapshot |
| Zinzino→It Works! Marketing International UC | Announced | 2026-02-11 | $30.0M |
A discussion or rumour is not a completed transaction. An unstated value is not zero.
1 postings in the preceding 12 months. The full 4-posting snapshot covers 4 employers.
0 tracked postings mention remote work.
Top skills across 4 tracked postings in the available jobs snapshot.
| Company | Open roles |
|---|---|
| Getinge ↗ | 13 |
| Sectra ↗ | 7 |
| Tobii Dynavox ↗ | 7 |
| Joint Academy ↗ | 5 |
| Hypocampus ↗ | 5 |
| NuvoAir ↗ | 3 |
| Molnlycke Health Care ↗ | 3 |
| Neko Health ↗ | 3 |
| Company | Employees |
|---|---|
| Sectra ↗ | 1,093 |
| Apotea ↗ | 800 |
| Medtanken ↗ | 800 |
| Raysearch laboratories ↗ | 375 |
| Surgical Science Sweden ↗ | 259 |
| silex microsystems ↗ | 258 |
| Min Doktor ↗ | 229 |
| Zinzino ↗ | 213 |
580 founders and chief executives across 408 companies.
Advisor - Heritage Holdings. Stockholm University Master of Science 2011
Co-Founder Neko Health, Prima Materia, Helsing.
Founder Centrumkliniken Uppsala Familjedoktorerna, ex-SEB. Uppsala University
Ex-Essity, BSN medical, EQT Partners, Beiersdorf. Karlstad University BSc 1993
ETH Zurich MSc 2008, University of Geneva PhD 2012
Co-Founder Madajo. ex-Freelance Web Developer, Circuit, Ottoboni, Adoy.
Ex-Depict, Co-Founder Programmeringsveckan. KTH Royal Institute of Technology BSc 2018, New York University MSc 2020
Immunovia, ex-Myriad Genetics, ex-Astute Solutions, Northwestern University - Kellogg School of Management, 1999
Elypta, ex-Praktikertjanst, ex-Arthur D Little, University of Cambridge, 2013
Ex-CEO Vital T, Docly Healthcare, M D International, Min Doktor. Lund University 1992
Zenicor Medical Systems, ex-Wiley, ex-Doctrin, Stockholm School of Economics Executive Education, 2021
Ex-The Mobile Life, Wireless Broadband Alliance, Boingo Wireless. Lund School of Economics MSc 2002
60 profiles with education records.
5 profiles with prior-work records.
Profiles cover recorded founders and leaders; contact details remain in Radar.
192,484 articles in the measured 12-month window.
Healthtech coverage across Sweden · articles per complete quarter
| Quarter | Articles |
|---|---|
| 2021Q2 | 26,425 |
| 2021Q3 | 26,479 |
| 2021Q4 | 25,694 |
| 2022Q1 | 30,088 |
| 2022Q2 | 33,399 |
| 2022Q3 | 30,035 |
| 2022Q4 | 36,886 |
| 2023Q1 | 38,967 |
| 2023Q2 | 37,308 |
| 2023Q3 | 39,044 |
| 2023Q4 | 33,801 |
| 2024Q1 | 42,102 |
| 2024Q2 | 48,521 |
| 2024Q3 | 45,654 |
| 2024Q4 | 47,012 |
| 2025Q1 | 64,543 |
| 2025Q2 | 39,104 |
| 2025Q3 | 113,189 |
| 2025Q4 | 20,913 |
| 2026Q1 | 28,288 |
Article volume measures coverage, not market sales.
448 recorded company events across 61 companies; percentages use that event total.
Healthtech coverage across Sweden · ranked by full-period article count.
Recent and prior counts use the source comparison windows.
Healthtech coverage across Sweden
| Keyword | Recent | Prior | Change |
|---|---|---|---|
| countries | 4,193 | 1,858 | 126% |
| tariff negotiations | 607 | 114 | 432% |
| final match recaps | 362 | 141 | 157% |
| women\'s champions league | 357 | 198 | 80% |
| free trade deals | 331 | 52 | 537% |
| ski competitions | 317 | 198 | 60% |
| trade dispute mechanisms | 313 | 46 | 580% |
| thrash rock elements | 310 | 27 | 1048% |
| bilateral trade | 309 | 42 | 636% |
| ice sports | 308 | 94 | 228% |
| summer olympics athletics | 35 | 276 | -87% |
| olympic career milestones | 67 | 271 | -75% |
| budget motel | 6 | 268 | -98% |
| olympians career highlights | 67 | 268 | -75% |
| motel | 0 | 262 | -100% |
Healthtech coverage across Sweden
territories, disputed islands, countries
8.2% critical · 6.9% positiveice palace hotel, ice hotel, budget motel
35.4% critical · 42.6% positivequarterly results, earnings report, dc fast-charging deployment
29.8% critical · 48.6% positiveHealthtech coverage across Sweden. Topic labels describe recorded classifications and can include broad context.
53,214 papers in the recorded worldwide scope.
Tone counts: 46,301 positive · 2,052 neutral · 4,861 negative.
Landmark: Implementation strategies: recommendations for specifying and reporting
Landmark: Deep Learning for Health Informatics
Landmark: Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
Common problems researchers identify · 0119.0% of this theme group
Examines barriers and factors affecting resilience in health care delivery and administration.
Health informatics (400) · Health administration (281) · Nursing research (250) · Public health (273)
Resilient Health Care: a systematic review of conceptualisations, study methods and factors that develop resilience
Health systems resilience in practice: a scoping review to identify strategies for building resilience
| Year | Share index |
|---|---|
| 2022 | 23.2 |
| 2023 | 21.1 |
| 2024 | 27.6 |
| 2025 | 44.8 |
Common problems researchers identify · 0218.9% of this theme group
Highlights difficulties in multi‑target discovery, repurposing, and regulatory pathways for new therapies.
Drug discovery (321) · Drug (197) · Drug development (103) · Disease (155)
A perspective on multi‐target drug discovery and design for complex diseases
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
| Year | Share index |
|---|---|
| 2022 | 157.3 |
| 2023 | 161.8 |
| 2024 | 169.7 |
| 2025 | 211.5 |
Common problems researchers identify · 0315.9% of this theme group
Analyzes shortcomings in eHealth adoption, equity, and integration within universal health coverage efforts.
Digital health (627) · Health care (357) · Digital transformation (69) · eHealth (97)
Technology and Universal Health Coverage: Examining the role of digital health
Engagement With and Acceptability of Digital Media Platforms for Use in Improving Health Behaviors Among Vulnerable Families: Systematic Rev
| Year | Share index |
|---|---|
| 2022 | 538.7 |
| 2023 | 553.0 |
| 2024 | 540.4 |
| 2025 | 843.9 |
Common problems researchers identify · 0414.7% of this theme group
Identifies practical and methodological challenges limiting telemedicine and telerehabilitation uptake.
Telemedicine (604) · Telehealth (394) · Health care (334) · Telerehabilitation (53)
Opportunities and challenges for telehealth within, and beyond, a pandemic
Strategies for Evaluating Telehealth
| Year | Share index |
|---|---|
| 2022 | 542.2 |
| 2023 | 554.7 |
| 2024 | 541.1 |
| 2025 | 844.0 |
Common problems researchers identify · 0511.7% of this theme group
Discusses diagnostic, biomarker, and resistance issues that constrain personalized cancer treatment.
Precision medicine (480) · Personalized medicine (238) · Disease (116) · Precision oncology (28)
Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance
Personalizing Oncology: Perspectives and Prospects
| Year | Share index |
|---|---|
| 2022 | 1255.2 |
| 2023 | 1115.6 |
| 2024 | 1012.0 |
| 2025 | 1296.9 |
Common problems researchers identify · 0610.9% of this theme group
Explores safety concerns, energy constraints, and regulatory gaps for wearable and moderate‑risk devices.
Medical device (221) · Wearable computer (50) · Medical equipment (27) · Risk analysis (34)
Energy sources and their development for application in medical devices
Medical Devices and Health — Creating a New Regulatory Framework for Moderate-Risk Devices
| Year | Share index |
|---|---|
| 2022 | 40.4 |
| 2023 | 42.2 |
| 2024 | 43.7 |
| 2025 | 72.1 |
Common problems researchers identify · 078.8% of this theme group
Reviews how COVID‑19 amplified usage pressures and evaluation challenges for remote care.
Pandemic (394) · Coronavirus disease 2019 (274) · 2019-20 coronavirus outbreak (69) · Telemedicine (258)
Quantifying the Impact of COVID-19 on Telemedicine Utilization: Retrospective Observational Study
Telemedicine Evaluations in Neuro-Ophthalmology During the COVID-19 Pandemic: Patient and Physician Surveys
| Year | Share index |
|---|---|
| 2022 | 655.3 |
| 2023 | 440.6 |
| 2024 | 327.7 |
| 2025 | 212.1 |
Cautions · 0119.8% of this theme group
Calls for careful assessment of effectiveness, patient satisfaction, and long‑term health impacts.
Telemedicine (762) · Telehealth (476) · Telerehabilitation (118) · Health care (319)
The Role of Telemedicine in Improving Healthcare Outcome: A Review
Assessing the Efficiency and Patient Satisfaction of Telemedicine in Managing Chronic Health Conditions
| Year | Share index |
|---|---|
| 2022 | 51.7 |
| 2023 | 48.4 |
| 2024 | 44.2 |
| 2025 | 63.5 |
Cautions · 0219.8% of this theme group
Warns of technical, quality, and equity hurdles when scaling e‑health tools in diverse settings.
Health informatics (239) · Health administration (157) · Nursing research (113) · Medical device (92)
Challenges of using e-health technologies to support clinical care in rural Africa: a longitudinal mixed methods study exploring primary hea
Development and analysis of quality assessment tools for different types of patient information – websites, decision aids, question prompt l
| Year | Share index |
|---|---|
| 2022 | 23.2 |
| 2023 | 21.1 |
| 2024 | 27.6 |
| 2025 | 44.8 |
Cautions · 0315.3% of this theme group
Notes the need for robust biomarkers and predictive models before clinical adoption.
Drug discovery (202) · Drug (160) · Pharmacogenomics (109) · Pharmacogenetics (64)
Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape
Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologic
| Year | Share index |
|---|---|
| 2022 | 154.6 |
| 2023 | 158.9 |
| 2024 | 165.9 |
| 2025 | 206.7 |
Cautions · 0414.7% of this theme group
Highlights variability in adoption, efficacy, and user experience for digital psychological therapies.
Digital health (480) · Psychological intervention (265) · Mental health (159) · Health care (262)
Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review
Digital Health Interventions for Promoting Healthy Aging: A Systematic Review of Adoption Patterns, Efficacy, and User Experience
| Year | Share index |
|---|---|
| 2022 | 790.2 |
| 2023 | 807.5 |
| 2024 | 810.9 |
| 2025 | 1159.7 |
Cautions · 0511.2% of this theme group
Examines clinician perspectives and systemic obstacles that emerged during pandemic remote care.
Pandemic (431) · Coronavirus disease 2019 (360) · Telemedicine (348) · 2019-20 coronavirus outbreak (77)
Community Mental Health Clinicians’ Perspectives on Telehealth During the COVID-19 Pandemic: Mixed Methods Study
Exploring Ophthalmologists’ Adoption of Telemedicine during the COVID-19 Pandemic: A Mixed Methods Study
| Year | Share index |
|---|---|
| 2022 | 544.1 |
| 2023 | 376.7 |
| 2024 | 243.3 |
| 2025 | 191.2 |
Cautions · 0610.3% of this theme group
Points to gaps in awareness, understanding, and practical uptake of personalized oncology approaches.
Precision medicine (249) · Personalized medicine (164) · Cancer (103) · Oncology (57)
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Sur
Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review
| Year | Share index |
|---|---|
| 2022 | 767.8 |
| 2023 | 1043.6 |
| 2024 | 798.0 |
| 2025 | 771.4 |
Cautions · 078.8% of this theme group
Raises concerns about bias, transparency, and governance when applying AI to precision medicine.
Applications of artificial intelligence (102) · Transformative learning (77) · Health care (188) · Precision medicine (102)
Artificial intelligence in healthcare: revolutionizing precision medicine, predictive analytics, and ethical considerations in autonomous di
Artificial Intelligence in Medicine: Transforming Diagnosis, Treatment, and Healthcare Delivery
| Year | Share index |
|---|---|
| 2022 | 534.7 |
| 2023 | 549.6 |
| 2024 | 538.1 |
| 2025 | 839.2 |
Opportunities · 0118.0% of this theme group
Shows promising models and HCI methods for improving clinical usability of digital health tools.
Digital health (282) · Health care (348) · Health informatics (142) · Psychological intervention (156)
Development of an Evidence-Based Conceptual Model of the Health Care Sector Under Digital Transformation: Integrative Review
HCI-modelling for improving the clinical usability of digital health technologies
| Year | Share index |
|---|---|
| 2022 | 541.3 |
| 2023 | 554.6 |
| 2024 | 543.2 |
| 2025 | 853.3 |
Opportunities · 0216.6% of this theme group
Highlights novel computational screening and docking strategies accelerating therapeutic discovery.
Drug discovery (282) · In silico (99) · Drug (156) · Docking (85)
Exploring Cimetidine\nas a Potential Therapeutic Attenuator\nagainst Amyloid Formation in Parkinson’s Disease: Spectroscopic\nand Microscopi
Design, Synthesis,\nand Biological Evaluation of 5‑Formyl-pyrrolo[3,2‑<i>b</i>]pyridine-3-carboxamides as New Selective, Potent,
| Year | Share index |
|---|---|
| 2022 | 167.5 |
| 2023 | 172.4 |
| 2024 | 180.4 |
| 2025 | 218.9 |
Opportunities · 0313.8% of this theme group
Demonstrates powerful docking and chemical‑space exploration techniques for targeted therapeutics.
Drug discovery (535) · Computational biology (222) · Drug (223) · Chemical space (66)
Assessing molecular docking tools: understanding drug discovery and design
Molecular Docking in Computer-Aided Drug Discovery: A Powerful Tool for Targeted Therapeutics
| Year | Share index |
|---|---|
| 2022 | 281.3 |
| 2023 | 298.1 |
| 2024 | 330.7 |
| 2025 | 367.6 |
Opportunities · 0413.7% of this theme group
Identifies new applications and methodological gains for remote physical and palliative care.
Telemedicine (475) · Telehealth (353) · Telerehabilitation (87) · Physical therapy (75)
Urgent and non-emergent telehealth care for seniors: Findings from a multi-site impact study
Telehealth for the study of palliative care communication: opportunities, methodological challenges, and recommendations
| Year | Share index |
|---|---|
| 2022 | 51.7 |
| 2023 | 48.4 |
| 2024 | 44.2 |
| 2025 | 63.5 |
Opportunities · 0512.7% of this theme group
Explores heterogeneous disease pathways and AI tools enabling personalized treatment plans.
Precision medicine (283) · Personalized medicine (216) · Disease (142) · Pharmacogenomics (61)
Pathways to personalized medicine—Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease
Deep Learning for Precision Medicine: Advancing Personalized Treatment Plans in Oncology
| Year | Share index |
|---|---|
| 2022 | 1255.2 |
| 2023 | 1115.6 |
| 2024 | 1012.0 |
| 2025 | 1296.9 |
Opportunities · 0612.7% of this theme group
Describes emerging wearable and IoT platforms for remote patient surveillance and global health support.
Wearable computer (117) · Medical device (84) · Remote patient monitoring (76) · Internet of Things (49)
Wearable technology. Health-care solutions for a growing global population.
IoT Based Effective Wearable Healthcare Monitoring System For Remote Areas
| Year | Share index |
|---|---|
| 2022 | 40.5 |
| 2023 | 42.2 |
| 2024 | 44.3 |
| 2025 | 74.3 |
Opportunities · 0712.5% of this theme group
Focuses on circulating tumor cell analysis and molecular markers advancing individualized oncology.
Cancer (241) · Precision medicine (207) · Breast cancer (90) · Lung cancer (44)
Bioinformatics-Based Analysis of Circulating Tumor Cells: A Methodological Overview of Personalized Cancer Treatment
[Molecular biomarkers in breast cancer : advances in precision medicine].
| Year | Share index |
|---|---|
| 2022 | 776.6 |
| 2023 | 1055.1 |
| 2024 | 810.2 |
| 2025 | 787.3 |
Orientation shares compared with 25,000 papers in the reference sample.
| Research orientation | This field | Reference sample |
|---|---|---|
| Promising | 29.7% | 36.9% |
| Problem-identifying | 29.0% | 9.9% |
| Descriptive | 18.8% | 17.8% |
| Breakthrough | 12.7% | 26.0% |
| Cautionary | 6.4% | 4.5% |
| Comparative | 2.5% | 3.9% |
| Critical | 0.9% | 1.0% |
Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.
| Concern / example paper | Papers | Share | Raised as a problem | Worldwide share |
|---|---|---|---|---|
| Privacy & surveillanceThe future of digital health with federated learning | 4,573 | 2.66% | 2,251 (49.2%) | 2.66% |
| Safety & misuseImpact of Rumors and Misinformation on COVID-19 in Social Media | 292 | 0.17% | 167 (57.2%) | 0.17% |
| Bias & fairnessChallenges and recommendations for wearable devices in digital health: Data quality, interoperability, health equity, fa | 99 | 0.06% | 45 (45.5%) | 0.06% |
| Hardware, e-waste & supply chainE-waste for health: recycling smartphones for health monitoring | 24 | 0.01% | 7 (29.2%) | 0.01% |
| Concentration of compute powerDemonopolizing Medical Knowledge | 16 | 0.01% | 7 (43.8%) | 0.01% |
| Labour & data workNew Work—New Interventions: Digital Occupational Health Interventions and the Co-Creation of a Human-Centered Future of | 11 | 0.01% | 6 (54.5%) | 0.01% |
| Energy & datacenter footprintSUSTAINABLE GREEN COMPUTING FOR MEDICAL APPLICATIONS: ADVANCING RESPONSIBLE HEALTHCARE IT | 10 | 0.01% | 4 (40.0%) | 0.01% |
| Carbon & emissions of computeSustainable AI-Enabled UAV Healthcare Logistics: Environmental, Social, and Governance Implications from a PRISMA-ScR Re | 3 | 0.0% | 1 (33.3%) | 0.0% |
| Water use | 0 | 0.0% | 0 (%) | 0.0% |
Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.
Published patent filings in the recorded source window.
Company counts, hiring and disclosed funding across the recorded hubs.
48.7% across the displayed hubs
22 companies hiring · $1.9B disclosed funding
Explore companies in Stockholm ↗
13.5% across the displayed hubs
11 companies hiring · $69.5M disclosed funding
Explore companies in Gothenburg ↗
11.8% across the displayed hubs
2 companies hiring · $245.6M disclosed funding
Explore companies in Lund ↗
9.4% across the displayed hubs
2 companies hiring · $99.0M disclosed funding
Explore companies in Uppsala ↗
9.1% across the displayed hubs
3 companies hiring · $170.0M disclosed funding
Explore companies in Malmo ↗
3.4% across the displayed hubs
1 companies hiring · $31.6M disclosed funding
Explore companies in Solna ↗
2.5% across the displayed hubs
0 companies hiring · $12.2M disclosed funding
Explore companies in Helsingborg ↗
1.7% across the displayed hubs
1 companies hiring · $11.4M disclosed funding
Explore companies in Linkoping ↗Clear definitions for making better comparisons.
It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.
No. A company can belong to several segments, so segment counts and funding can overlap.
A dash or unavailable panel means the current reviewed source snapshot does not support that figure.
Company ecosystem snapshot: 31 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.
Canonical landscape ↗